This site is intended for UK healthcare professionals.

Please select one of the following:

I am a UK healthcare professional
I am a member of the general public

Selecting 'I am a UK healthcare professional' will take you to the Accord UK Partner Platform.

Selecting ‘I am a member of the general public’ will take you to the Accord UK site.


Orange graphic

News

Oncodemia® course : Routine vaccinations in cancer

Articles / Short Read / 08.08.2024

Visit the Oncodemia® training platform
Oncodemia

Oncodemia®, created by Accord in collaboration with The Royal Marsden Trust, is an online training platform that provides bite-size information to support you with improving cancer patient care throughout the patient journey.

Sign up for free today to access the training course ‘Routine Vaccinations in Cancer’, which covers the following learning objectives:

  • Provide an overview of vaccines and immunocompromised status in cancer.
  • Identify different types of vaccines and their safety in cancer patients.
  • Provide advice on vaccination during and after systemic anticancer treatment.
  • Review recommendations for travel vaccines and travel medicines in cancer patients.
  • Discuss the safety of cancer patients when coming into contact with others during treatment.

Following completion of the course, with knowledge checks on the content, you should feel more confident in delivering cancer patient support on the topic of routine vaccinations.

To find out more, and access further specialised training modules, sign up for free at https://www.oncodemia.com

 

Date of prep: August 2024   UK-Gen-NP-01469

OTHER NEWS

01

Spotlight on Jamie Thorne, Pharmacist, Gravells Pharmacy, Llanelli, Wales

Read More

02

Innovation is vital for success in today’s Generics and Biosimilars market

Read More

03

The First Steps to Building a Web Presence for Your Pharmacy

Read More

Courses

01

Time management & Priorities

Read More

02

Controlled Drugs: Community Pharmacists

Read More

03

Pharmacy First: Navigating eligibility and consultation fees

Read More